BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20373367)

  • 1. Hemochromatosis gene (HFE) mutations and cancer risk: expanding the clinical manifestations of hereditary iron overload.
    Fargion S; Valenti L; Fracanzani AL
    Hepatology; 2010 Apr; 51(4):1119-21. PubMed ID: 20373367
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
    García Buey L; González Mateos F
    Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hereditary and acquired iron overload].
    de Korwin JD
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S304-12. PubMed ID: 17373275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop.
    Singh M; Ashwell M; Sanderson P; Cade J; Moreton J; Fairweather-Tait S; Roe M; Marx JJ; Worwood M; Cook JD
    Br J Nutr; 2006 Oct; 96(4):770-3. PubMed ID: 17010238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 7. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 9. HFE gene mutations and Wilson's disease in Sardinia.
    Sorbello O; Sini M; Civolani A; Demelia L
    Dig Liver Dis; 2010 Mar; 42(3):216-9. PubMed ID: 19640812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the HFE gene (H63D and C282Y) mutations in patients with iron overload, family members and controls from Antioquia, Northwest Colombia.
    Avila-Gomez IC; Latorre-Sierra G; Restrepo-Gutierrez JC; Correa-Arango G; Jimenez-Del-Rio M; Velez-Pardo C
    Clin Genet; 2008 Jan; 73(1):92-3. PubMed ID: 18005180
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS; Lorca RR; Bernabeu-Wittel M; Garcia-Junco PS; Andreu EP; de la Fuente JC
    J Intern Med; 2005 Apr; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
    Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
    Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HFE gene mutations and risk of hepatocellular carcinoma].
    Solís Herruzo JA; Solís Muñoz P
    Rev Esp Enferm Dig; 2007 Jul; 99(7):369-75. PubMed ID: 17973579
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexistence of HFE and rare UGT1A1 genes mutations in patients with iron overload related liver injury.
    Sikorska K; Romanowski T; Stalke P; Jaskiewicz K; Bielawski KP
    Adv Med Sci; 2010; 55(1):108-10. PubMed ID: 20371435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
    Loria P; Lonardo A; Carulli N
    Hepatology; 2004 Jun; 39(6):1748; author reply 1749. PubMed ID: 15185321
    [No Abstract]   [Full Text] [Related]  

  • 19. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
    Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
    Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.